硕世生物
(688399)
| 流通市值：34.30亿 | | | 总市值：34.30亿 |
| 流通股本：1.24亿 | | | 总股本：1.24亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 147,426,847.79 | 78,583,971.79 | 339,047,470.66 | 257,507,844.76 |
| 营业总成本 | 178,153,329.2 | 90,699,617.91 | 424,137,643.57 | 306,781,790.65 |
| 其他经营收益 | | | | |
| 营业利润 | 24,865,765.08 | 25,224,954.17 | -29,966,624.57 | 6,954,397.41 |
| 利润总额 | 26,711,897.89 | 26,662,962.33 | -32,057,765.5 | 7,125,468.73 |
| 净利润 | 19,564,558.98 | 21,122,244.19 | -41,078,454.55 | 3,151,662.14 |
| 每股收益 | | | | |
| 其他综合收益 | -4,537,383.27 | -2,308,772.26 | 4,220,759.69 | -1,054,497.65 |
| 综合收益总额 | 15,027,175.71 | 18,813,471.93 | -36,857,694.86 | 2,097,164.49 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,827,554,997.77 | 1,795,205,294.77 | 1,694,918,455.26 | 1,789,319,352.05 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,893,736,324.9 | 1,869,000,843.2 | 1,859,432,586.42 | 1,859,313,348.11 |
| 资产总计 | 3,721,291,322.67 | 3,664,206,137.97 | 3,554,351,041.68 | 3,648,632,700.16 |
| 流动负债: | | | | |
| 流动负债合计 | 594,212,355.83 | 539,903,108.76 | 467,575,520.05 | 539,272,708.84 |
| 非流动负债: | | | | |
| 非流动负债合计 | 183,415,671.98 | 176,853,438.13 | 158,139,402.48 | 141,769,012.82 |
| 负债合计 | 777,628,027.81 | 716,756,546.89 | 625,714,922.53 | 681,041,721.66 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,943,663,294.86 | 2,947,449,591.08 | 2,928,636,119.15 | 2,967,590,978.5 |
| 股东权益合计 | 2,943,663,294.86 | 2,947,449,591.08 | 2,928,636,119.15 | 2,967,590,978.5 |
| 负债和股东权益合计 | 3,721,291,322.67 | 3,664,206,137.97 | 3,554,351,041.68 | 3,648,632,700.16 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 197,510,744.83 | 108,650,734.06 | 423,042,140.28 | 316,241,777.33 |
| 经营活动现金流出小计 | 202,331,919.26 | 111,298,711.1 | 392,700,943.22 | 296,816,824.36 |
| 经营活动产生的现金流量净额 | -4,821,174.43 | -2,647,977.04 | 30,341,197.06 | 19,424,952.97 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 622,319,682.75 | 517,148,240.11 | 4,399,856,877.45 | 3,612,403,921.57 |
| 投资活动现金流出小计 | 925,823,933.75 | 660,952,878.7 | 4,593,143,120.06 | 4,067,544,092.52 |
| 投资活动产生的现金流量净额 | -303,504,251 | -143,804,638.59 | -193,286,242.61 | -455,140,170.95 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 370,827,600 | 231,077,600 | 648,044,417 | 552,646,675.78 |
| 筹资活动现金流出小计 | 198,598,187.34 | 87,929,856.83 | 810,151,324.52 | 631,220,235.45 |
| 筹资活动产生的现金流量净额 | 172,229,412.66 | 143,147,743.17 | -162,106,907.52 | -78,573,559.67 |
| 汇率变动对现金及现金等价物的影响 | -2,100,581.71 | -3,108,610.55 | -1,443,103.41 | -1,448,843.26 |
| 现金及现金等价物净增加额 | -138,196,594.48 | -6,413,483.01 | -326,495,056.48 | -515,737,620.91 |
| 期末现金及现金等价物余额 | 345,316,469.64 | 477,099,581.11 | 483,513,064.12 | 294,270,499.69 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -138,196,594.48 | - | -326,495,056.48 | - |